Shanghai MicroPort MedBot (Group) (HKG:2252) has obtained approval for its Toumai Single-arm and Single-port Laparoscopic Surgical Robot from China's National Medical Products Administration, a Tuesday Hong Kong bourse filing said.
The product is from the same series as the medical device company's core product, Toumai Laparoscopic Surgical Robot, which can complete complex surgeries with a minimally invasive approach.